SURVYR

ATRC

AtriCure, Inc.
$61.51
+$0.43 (0.70%)Oct 27 close
Healthcare CompareTechnicals
1M3M6M1Y2Y
-30%-6%+19%+44%+69%Oct 2025Oct 2026Apr 202652w high $61.7052w low $25.36
ATRCSPY
Wall St. Highest PT $68.00 (+10.6%) Wall St. Avg PT $57.56 (-6.4%)
$26$37$48$59$70POC $30Hi $68Avg $58
Underwater Drawdown %Max DD -39.0%Current 0.0%
0.0%-39.0%
Relative Strength vs SPY+55.1% vs SPYOutperforming
+63%0%-63%
1W
+$3.84 (6.66%)
1M
+$3.13 (5.36%)
3M
+$21.76 (54.74%)
6M
+$33.03 (115.98%)
YTD
+$21.95 (55.49%)
1Y
+$25.04 (68.66%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Buy
10 analysts · mean score 1.90
1 = Strong Buy · 5 = Sell
Strong Buy330%
Buy440%
Hold330%
Underperform00%
Sell00%
Wall Street consensus
Analyst price targets
Current price$61.51
Average target$57.56
−$3.95 (−6.4%) downsideaverage target vs current price
CurrentAverageMedian
Low$36.00
Median$60.00
High$68.00
12-month Wall Street target range
Recent analyst rating changes · 30
Reiterated
2026-10-21 · Citizens reiterated Market Outperform on ATRC
Reiterated
2026-10-12 · BTIG reiterated Buy on ATRC
Downgrade
2026-10-02 · Freedom Capital Markets downgraded ATRC from Buy to Hold
Reiterated
2026-09-02 · Needham reiterated Buy on ATRC
Reiterated
2026-08-27 · Piper Sandler reiterated Overweight on ATRC
Reiterated
2026-08-24 · BTIG reiterated Buy on ATRC
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$3.0B
P/E (last 12 months)280.8
P/E (next 12 months, estimated)135.9
52-week range$25.36 – $61.70
Revenue growth (latest quarter vs a year ago)+12.8%
Dividend yieldNo dividend
Analyst consensusBuy (9)
Average analyst price target$57.56 (-6%)

What they do

AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products.

Healthcare · Medical Instruments & Supplies
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for ATRC yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

ATRC earningsNext report in 6 days
Next report · quarter Sep 2026
Tue Nov 3, 2026After the close
EPS consensus$0.01 range -$0.03–$0.05
Revenue consensus$151.2M 10 analysts
Last 4 quarters · EPS vs estimate
Jul 23, 2026$0.18est $0.02+650.3%Above estimates
Feb 17, 2026$0.06est -$0.04+249.9%Above estimates
Oct 29, 2025-$0.01est -$0.12+91.5%Above estimates
Jul 29, 2025-$0.02est -$0.16+87.7%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-25 13:25:50 ET
24-0724-1025-0225-0425-0725-1026-0226-07-0.220.18
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$153.6M+12.8%
2026-03-31$141.2M–
2025-12-31$140.5M–
2025-09-30$134.3M–
2025-06-30$136.1M–

News & catalysts

More news
AtriCure to Announce Third Quarter 2026 Financial Results
Business Wire · Oct 13
AtriCure (ATRC) Stock Gets Fair Value Bump As Analysts Weigh Procedure Growth And Risks
Simply Wall St. · Oct 04
AtriCure (ATRC) Stock Looks Rich Against Its Sales Base
Simply Wall St. · Sep 25
Why AtriCure (ATRC) Is Back In The Spotlight
Simply Wall St. · Sep 25
Atricure Insider Sold Shares Worth $271,140, According to a Recent SEC Filing
MT Newswires · Sep 24
Rating changes
Reiterated
2026-10-21 · Citizens reiterated Market Outperform on ATRC
Reiterated
2026-10-12 · BTIG reiterated Buy on ATRC
Downgrade
2026-10-02 · Freedom Capital Markets downgraded ATRC from Buy to Hold
Reiterated
2026-09-02 · Needham reiterated Buy on ATRC
Reiterated
2026-08-27 · Piper Sandler reiterated Overweight on ATRC
Reiterated
2026-08-24 · BTIG reiterated Buy on ATRC

Third-party analyst actions, not SURVYR.'s views. All rating changes

Insider trades
Privitera Salvatore
Chief Technical Officer · 2026-09-23
Sell
$271.1K
Groves Regina E
Director · 2026-09-11
Sell
$288.1K
Privitera Salvatore
Chief Technical Officer · 2026-09-08
Sell
$201.1K
Privitera Salvatore
Chief Technical Officer · 2026-09-02
Sell
$407.6K
Dahlquist Karl S.
Chief Legal Officer · 2026-08-24
Sell
$458.1K
Yuen Maggie
Director · 2026-08-05
Sell
$134.5K
Prange Karen
Director · 2026-08-05
Sell
$138.3K
Noznesky Justin J
Chief Mktg & Strategy Officer · 2026-07-29
Sell
$239.9K
Wehrwein Sven
Director · 2026-07-28
Sell
$946.0K
Doraiswamy Vinayak
Chief Scientific Officer · 2026-07-28
Sell
$233.3K
None
None · None
Sell
–

Stats refreshed 2026-10-25 13:25:50 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026